Tops & Flops Stocks
| Security | Change (%) | 1w | 1m ▲ | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cytosorbents Corp. | 8.940% | 25.034% | 14.268% | -71.059% | -5.301% | -85.686% | - |
| Corbus Pharmaceuticals Holding Inc. | 2.160% | 2.174% | 14.634% | 36447.434% | 36447.434% | 7.823% | - |
| Pulmatrix Inc. | -0.530% | 9.357% | 14.724% | -18.519% | 14.164% | -87.920% | -88.313% |
| MannKind Corp. | 5.750% | 2.177% | 14.949% | 39.356% | 47.626% | 20.635% | 375.621% |
| United Therapeutics | 0.650% | -1.480% | 15.049% | 51.553% | 47.692% | 84.151% | 330.588% |
| Anavex Life Sciences Corp | 8.520% | 8.583% | 15.998% | -42.450% | -52.006% | -80.908% | 34.693% |
| Krystal Biotech | 1.230% | 4.125% | 16.097% | 59.189% | 52.328% | - | - |
| Arca Biopharma | -1.140% | 0.568% | 17.219% | 90.836% | 127.653% | 21.233% | -93.757% |
| Madrigal Pharmaceuticals inc. | 5.410% | 3.150% | 18.543% | 34.284% | 27.010% | 214.035% | 195.282% |
| Ionis Pharmaceuticals Inc. | 0.380% | -0.456% | 21.003% | 14.589% | -4.379% | 33.344% | -23.116% |
| Sarepta Therapeutics | 0.500% | -4.144% | 22.548% | 40.795% | 58.171% | 127.339% | 4.394% |
| Kewaun.scientific Dl2,50 | -0.470% | 2.941% | 22.807% | 228.125% | 73.554% | 262.069% | 165.587% |
| VBI Vaccines Inc. | -0.290% | 12.231% | 23.007% | -35.943% | 28.113% | -99.125% | -97.273% |
| TG Therapeutics Inc. | 0.760% | 6.959% | 23.271% | -20.589% | 12.540% | -44.677% | - |
| Aclaris Therapeutics Inc | 8.070% | 8.571% | 25.346% | -87.468% | 24.000% | -92.094% | - |
| Emergent Biosolutions Inc. | 3.850% | 14.208% | 31.355% | 17.105% | 237.702% | -84.913% | -82.022% |
| Ocular Therapeutix Inc. | 0.590% | -0.807% | 34.002% | 37.724% | 46.520% | -45.107% | 43.461% |
| Qualigen Therapeutics Inc. | -9.090% | 62.264% | 42.541% | -70.379% | -48.503% | -98.404% | - |
| Eagle Pharmaceuticals Inc | 5.530% | -0.971% | 48.256% | -72.283% | 13.839% | -86.066% | -89.619% |
| Seres Therapeutics Inc | 13.480% | 30.038% | 56.292% | -79.066% | -31.924% | -94.855% | - |
| Alnylam Pharmace. | 1.470% | 4.016% | 66.631% | 34.073% | 33.164% | 61.826% | 279.794% |